The U.S. Department of Transportation (DOT) will require drug testing for four additional semi-synthetic opioids starting Jan. 1, 2018.

The four opioids are hydrocodone, oxycodone, hydromorphone, and oxymorphone. These drugs are also known as Oxycontin, Percodan, Percocet, Vicodin, Lortab, Norco, Dilaudid, and Exalgo.

The opioids must be tested for in addition to current requirements, which include testing for marijuana, cocaine, amphetamines, phencyclidine, and opiates.

If an employee tests positive for any of these drugs, including the opioids, the Medical Review Officer (MRO) will interview the employee to determine if the drugs were taken for a legitimate medical reason. Employees in this situation should provide a valid prescription to the MRO. The officer will determine whether the prescription is valid.

As of Jan. 1, employees with an initial positive drug test will have up to five days to get their prescribing physician to contact the MRO. This is the employee’s responsibility. The MRO will ask the employee’s physician if he or she would be able to safely perform their job duties while taking the prescribed medication or if the medication could be changed to one that would not pose a safety risk while on the job.

Employers must remove an employee immediately from safety-sensitive job duties if the employee receives a positive drug test. Employers must also provide the employee with a list of qualified Substance Abuse Professionals (SAP) in their area.

To return to safety-sensitive job duties, employees must complete the return-to-duty process: an evaluation from a SAP, education or treatment, and a negative return-to duty drug test. Upon returning to work, an employee is subject to follow-up testing for a year to five years, depending on the SAP’s recommendations.

DOT suggests employees who take or are being prescribed any medication to tell their physician about the nature of their work beyond their job title. This conversation should include detailed description of an employee’s job duties so the physician can prescribe the most appropriate medication or treatment.

Don’t be afraid to ask if a medication will have adverse effects that could limit the ability for you to safely do your job.

Click here to read the notice from the DOT.

Whitney Jones | Technical Writer
Industrial Training Services, Inc.
LinkedIn | FaceBook | Twitter

Posted by: ITS-Training at 9:31 am on December 29th, 2017

Industrial Training Services, Inc., a woman-owned small business headquartered in Murray, Kentucky, has provided innovative training products and best-in-class support to the energy industry for over 30 years. ITS is dedicated to maintaining lasting customer relationships by providing groundbreaking and industry-proven compliance tools, training, and products to streamline complex operations and help meet safety, regulatory, and qualification standards.

ITS has been the first to market for a variety of digital products to support the pipeline industry, helping to replace cumbersome, outdated paper processes and give business leaders the peace of mind their employees are well-trained and records are secure.

Industrial Training Services has been approved as an Accredited Provider by the International Association for Continuing Education and Training (IACET).  In obtaining this accreditation, ITS has demonstrated that it complies with the ANSI/IACET Standards which are widely recognized as standards of good practice internationally. As a result of their Accredited Provider membership status, ITS is authorized to offer IACET CEUs for its programs that qualify under the ANSI/IACET Standards.

ITS clients are found in all 50 states and are among the largest energy compliance providers in the nation. Follow ITS on LinkedIn, Twitter, Facebook, and YouTube.

© 2021 Industrial Training Services, Inc.Information Security Management | Terms of Use | Privacy Policy